2026 GOLD update: key recommendations for primary care on COPD diagnosis, assessment, prevention, treatment, exacerbations and emerging technologies.
Learn why earlier COPD diagnosis and better clinical control during follow-up are essential to reduce exacerbations, improve quality of life and optimise patient outcomes.
GOLD and GLI provide a joint position on spirometry for diagnosing COPD, supporting the fixed FEV1/FVC ratio in the appropriate clinical context.
Analysis of COPD management in primary care highlighting the role and underutilisation of nursing consultations and healthcare utilisation patterns in real-world patients.
Joint GOLD/GLI statement on spirometry to define airflow obstruction and confirm COPD diagnosis, aiming to harmonize criteria and improve global practice.
Conoce el estudio 3P que analiza los factores que predicen la progresión de la pre-EPOC a EPOC en fumadores con espirometría normal.
Commentary in the European Respiratory Journal (June 2025) reaffirming spirometry as the essential diagnostic tool for COPD.
Study of five European cohorts found no association between residential greenness or urban green space and lung function throughout childhood and adolescence.
Un estudio reciente en Osona (Cataluña) refleja que 20,7% de jóvenes presenta alteraciones espirométricas. También revela síntomas y factores de riesgo en la población joven ambulatoria.
Airflow limitation can worsen or improve from school age to adulthood at all severity levels. This study examines lung function changes and the impact of BMI and wheezing, highlighting key health interventions.
